UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

The New England journal of medicine, 1996-10, Vol.335 (18), p.1333-1342

1996

Volltextzugriff (PDF)

Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

The New England journal of medicine, 2017-04, Vol.376 (14), p.1321-1331

2017

Volltextzugriff (PDF)

Age and outcome with contemporary thrombolytic therapy : Results from the GUSTO-I trial

Circulation (New York, N.Y.), 1996-10, Vol.94 (8), p.1826-1833

1996

Volltextzugriff (PDF)

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention : The role of dual drug resistance

Journal of the American College of Cardiology, 2006-01, Vol.47 (1), p.27-33

2006

Volltextzugriff (PDF)

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

JAMA : the journal of the American Medical Association, 2004-08, Vol.292 (6), p.696

2004

Volltextzugriff (PDF)

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

JAMA : the journal of the American Medical Association, 2003-02, Vol.289 (7), p.853

2003

Volltextzugriff (PDF)

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

JAMA : the journal of the American Medical Association, 2004-11, Vol.292 (17), p.2096

2004

Volltextzugriff (PDF)

Recombinant hirudin for unstable angina pectoris : a multicenter, randomized angiographic trial

Circulation (New York, N.Y.), 1994-04, Vol.89 (4), p.1557-1566

1994

Volltextzugriff (PDF)

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (1), p.45

2004

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

Circulation (New York, N.Y.), 2001-12, Vol.104 (23), p.2767-2771

2001

Volltextzugriff (PDF)

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

The American journal of cardiology, 2004-05, Vol.93 (9), p.1092-1096

2004

Volltextzugriff (PDF)

Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction

Circulation (New York, N.Y.), 2000-01, Vol.101 (1), p.27-32

2000

Volltextzugriff (PDF)

Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial

Circulation (New York, N.Y.), 1999-06, Vol.99 (21), p.2720-2732

1999

Volltextzugriff (PDF)

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

The Lancet (British edition), 2001-04, Vol.357 (9262), p.1063-1068

2001

Volltextzugriff (PDF)

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)

The American heart journal, 2002-05, Vol.143 (5), p.847-853

2002

Volltextzugriff (PDF)

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Circulation (New York, N.Y.), 1999-12, Vol.100 (25), p.2477-2484

1999

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa antagonists : What are the relevant issues concerning their pharmacology and clinical use?

Circulation (New York, N.Y.), 1999-07, Vol.100 (4), p.437-444

1999

Volltextzugriff (PDF)

Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes

Arteriosclerosis, thrombosis, and vascular biology, 2005-05, Vol.25 (5), p.1065

2005

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

European heart journal, 2002-09, Vol.23 (18), p.1441-1448

2002

Volltextzugriff (PDF)

Myonecrosis After Revascularization Procedures

Journal of the American College of Cardiology, 1998-02, Vol.31 (2), p.241-251

1998

Volltextzugriff (PDF)

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

The New England journal of medicine, 1999-07, Vol.341 (5), p.319-327

1999

Volltextzugriff (PDF)

Initial Experience With a Magnetic Navigation System for Percutaneous Coronary Intervention in Complex Coronary Artery Lesions

Journal of the American College of Cardiology, 2006-02, Vol.47 (3), p.515-521

2006

Volltextzugriff (PDF)

Dobutamine echocardiography in myocardial hibernation : optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty

Circulation (New York, N.Y.), 1995-02, Vol.91 (3), p.663-670

1995

Volltextzugriff (PDF)

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

The Lancet (British edition), 1998-07, Vol.352 (9122), p.87-92

Topol, Eric J

1998

Volltextzugriff (PDF)

Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy

Circulation (New York, N.Y.), 1998-10, Vol.98 (17), p.1750-1755

1998

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(162)

Publikationsform

Artikel
(185)

Sprache

Englisch
(185)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(176)
Life Sciences & Biomedicine
(175)
Cardiovascular System & Cardiology
(148)
Humans
(145)
Cardiac & Cardiovascular Systems
(144)
Biological And Medical Sciences
(125)
Medical Sciences
(125)
Male
(91)
Female
(89)
Middle Aged
(89)
Aged
(67)
Pharmacology. Drug Treatments
(61)
Blood. Blood Coagulation. Reticuloendothelial System
(55)
Peripheral Vascular Disease
(47)
Angioplasty, Balloon, Coronary
(46)
Cardiology. Vascular System
(42)
Platelet Glycoprotein Gpiib-Iiia Complex - Antagonists & Inhibitors
(40)
Treatment Outcome
(40)
Heart
(37)
Platelet Aggregation Inhibitors - Therapeutic Use
(35)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

Age and outcome with contemporary thrombolytic therapy : Results from the GUSTO-I trial

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention : The role of dual drug resistance

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

Recombinant hirudin for unstable angina pectoris : a multicenter, randomized angiographic trial

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction

Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Platelet glycoprotein IIb/IIIa antagonists : What are the relevant issues concerning their pharmacology and clinical use?

Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

Myonecrosis After Revascularization Procedures

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

Initial Experience With a Magnetic Navigation System for Percutaneous Coronary Intervention in Complex Coronary Artery Lesions

Dobutamine echocardiography in myocardial hibernation : optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy

Suchergebnisse filtern